Stay updated on FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab + Tremelimumab Clinical Trial
Sign up to get notified when there's something new on the FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab + Tremelimumab Clinical Trial page.

Latest updates to the FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab + Tremelimumab Clinical Trial page
- Check3 days agoChange DetectedSitewide outage warning and a note about intermittent delays to NCBI services were added, indicating a temporary service disruption. The previous revision tag v3.6.4 was removed and updated to v3.6.5.SummaryDifference0.1%

- Check10 days agoChange DetectedAdded metadata about the study's last known status, sponsor, and last verification date, and removed the note indicating no longer recruiting participants, altering how the page presents current enrollment information.SummaryDifference0.3%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4, indicating a platform version update behind the page. This change represents a backend software bump and does not alter study content or visible information.SummaryDifference0.0%

- Check45 days agoChange DetectedThe page's revision label was updated from v3.6.1 to v3.6.3, indicating a newer version of the study details page.SummaryDifference0.0%

- Check53 days agoChange DetectedA new revision tag appears: v3.6.1 replaces the previous v3.6.0 on the page. This signals a small update to the page's underlying build rather than any changes to study information.SummaryDifference0.0%

- Check61 days agoChange DetectedThe page now displays a recruitment status update indicating enrollment has ended. It also adds new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) and adjusts/removes some header labels and revision identifiers (Intervention/Treatment and Revision: v3.5.5).SummaryDifference0.3%

Stay in the know with updates to FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab + Tremelimumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab + Tremelimumab Clinical Trial page.